A, B., RL, F., A, M., JB, H., AMO, B., AR, P., . . . CG, S. (2012). Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer’s disease models. Dove Medical Press.
Chicago Style (17th ed.) CitationA, Bernardi, Frozza RL, Meneghetti A, Hoppe JB, Battastini AMO, Pohlmann AR, Guterres SS, and Salbego CG. Indomethacin-loaded Lipid-core Nanocapsules Reduce the Damage Triggered by Aβ1-42 in Alzheimer’s Disease Models. Dove Medical Press, 2012.
MLA (8th ed.) CitationA, Bernardi, et al. Indomethacin-loaded Lipid-core Nanocapsules Reduce the Damage Triggered by Aβ1-42 in Alzheimer’s Disease Models. Dove Medical Press, 2012.
Warning: These citations may not always be 100% accurate.